(Critical Path Institute (C-Path)) C-Path announced today that a formal consultation between its Predictive Safety Testing Consortium and Japan's PMDA has resulted in an agreement on a first-of-its-kind approach to compare the levels of eight novel urinary kidney safety biomarkers in healthy Japanese volunteers to data collected on these same biomarkers in healthy Western volunteers in a bridging study.
from EurekAlert! - Technology, Engineering and Computer Science https://ift.tt/2ux0ROy
Wednesday, March 27, 2019
C-Path and Japan's PMDA collaborate on first-of-its-kind biomarker project
About Admin -
Author Description here.. Nulla sagittis convallis. Curabitur consequat. Quisque metus enim, venenatis fermentum, mollis in, porta et, nibh. Duis vulputate elit in elit. Mauris dictum libero id justo.